Technology
Health
Medical

Penumbra

$171.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.95 (-2.81%) Today
$0.00 (0.00%) As of 4:02 PM EDT after-hours

Why Robinhood?

You can buy or sell Penumbra and other stocks, options, ETFs, and crypto commission-free!

About PEN

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Read More Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.

Employees
2,200
Headquarters
Alameda, California
Founded
2004
Market Cap
6.09B
Price-Earnings Ratio
593.26
Dividend Yield
0.00
Average Volume
265.47K
High Today
$176.49
Low Today
$170.61
Open Price
$176.47
Volume
320.48K
52 Week High
$178.77
52 Week Low
$110.84

Collections

Technology
Health
Medical
Advertising and Marketing
Medical Devices
Business Services
2015 IPO
US

PEN Earnings

-$0.02
$0.06
$0.15
$0.23
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.